Spark Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-12,000
Closed -$633K 782
2017
Q2
$633K Hold
12,000
0.04% 467
2017
Q1
$666K Hold
12,000
0.04% 482
2016
Q4
$625K Sell
12,000
-23,500
-66% -$1.13M 0.05% 433
2016
Q3
$1.71M Hold
35,500
0.14% 222
2016
Q2
$1.97M Hold
35,500
0.18% 180
2016
Q1
$1.9M Hold
35,500
0.19% 179
2015
Q4
$1.83M Buy
+35,500
New +$1.76M 0.23% 130
2014
Q4
Sell
-32,800
Closed -$1.06M 778
2014
Q3
$1.06M Hold
32,800
0.16% 199
2014
Q2
$1.11M Sell
32,800
-5,800
-15% -$186K 0.17% 200
2014
Q1
$1.05M Sell
38,600
-30,800
-44% -$915K 0.16% 208
2013
Q4
$2.48M Sell
69,400
-98,100
-59% -$3.26M 0.43% 47
2013
Q3
$5.04M Sell
167,500
-52,100
-24% -$1.7M 1.15% 6
2013
Q2
$6.4M Buy
+219,600
New +$6.19M 1.71% 6

Other funds holding PBH

Spark Investment Management's PBH Position: Q3 2017 in Review

Spark Investment Management sold out of Prestige Consumer Healthcare (PBH) in Q3 2017, closing a stake of 12,000 shares — an estimated $633K sold.

Spark Investment Management first reported a position in PBH in Q2 2013 and held it in 13 quarters. The position peaked at $6.4M in Q2 2013. 239 funds tracked by Wall St. Rank hold PBH as of Q3 2017.

  • Spark Investment Management reported no remaining Prestige Consumer Healthcare position as of Q3 2017 after selling out during the quarter.
  • Spark Investment Management sold 12,000 Prestige Consumer Healthcare shares in Q3 2017, an estimated $633K.
  • Spark Investment Management first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 13 quarters.
  • Spark Investment Management's Prestige Consumer Healthcare position peaked at $6.4M in Q2 2013.
  • 239 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2017.

Based on Spark Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.